Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jul 15 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-0.91 Insider Own32.16% Shs Outstand43.29M Perf Week3.22%
Market Cap37.46M Forward P/E- EPS next Y-0.58 Insider Trans0.00% Shs Float29.93M Perf Month-42.24%
Income-31.04M PEG- EPS next Q-0.17 Inst Own26.84% Short Float2.53% Perf Quarter-23.51%
Sales0.00M P/S- EPS this Y35.00% Inst Trans-22.17% Short Ratio1.93 Perf Half Y-44.87%
Book/sh0.40 P/B2.10 EPS next Y11.03% ROA-123.61% Short Interest0.76M Perf Year-50.06%
Cash/sh0.30 P/C2.88 EPS next 5Y- ROE-180.94% 52W Range0.65 - 2.48 Perf YTD-38.48%
Dividend Est.- P/FCF- EPS past 5Y-50.62% ROI-143.03% 52W High-65.77% Beta0.07
Dividend TTM- Quick Ratio4.10 Sales past 5Y0.00% Gross Margin- 52W Low30.62% ATR (14)0.09
Dividend Ex-Date- Current Ratio4.10 EPS Y/Y TTM32.47% Oper. Margin0.00% RSI (14)42.75 Volatility6.87% 9.88%
Employees31 Debt/Eq0.33 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price7.47
Option/ShortNo / Yes LT Debt/Eq0.24 EPS Q/Q34.98% Payout- Rel Volume0.38 Prev Close0.88
Sales Surprise- EPS Surprise-19.05% Sales Q/Q- EarningsMay 09 AMC Avg Volume392.45K Price0.85
SMA20-7.95% SMA50-17.65% SMA200-23.88% Trades Volume148,757 Change-3.28%
Date Action Analyst Rating Change Price Target Change
Mar-18-24Initiated Laidlaw Buy $7.50
Aug-30-22Initiated H.C. Wainwright Buy $14
Jun-24-24 08:00AM
Jun-14-24 02:04PM
Jun-13-24 04:01PM
Jun-03-24 06:05AM
May-24-24 08:00AM
05:00PM Loading…
May-23-24 05:00PM
May-14-24 10:00AM
May-13-24 08:00AM
May-09-24 10:57PM
Apr-30-24 06:05AM
Apr-24-24 08:00AM
Apr-16-24 04:05PM
Apr-09-24 04:30PM
Mar-14-24 09:54PM
04:00PM Loading…
Mar-05-24 04:30PM
Feb-26-24 08:00AM
Feb-14-24 08:00AM
Jan-04-24 08:00AM
Dec-11-23 04:05PM
Dec-07-23 08:00AM
Dec-05-23 08:00AM
Nov-20-23 07:00AM
Nov-10-23 07:00AM
Nov-09-23 04:00PM
Nov-06-23 08:00AM
Nov-03-23 12:00PM
Nov-02-23 09:17AM
08:00AM Loading…
Nov-01-23 08:00AM
Oct-12-23 08:00AM
Sep-29-23 08:00AM
Sep-26-23 08:00AM
Sep-20-23 08:00AM
Sep-19-23 08:03AM
Sep-06-23 08:00AM
Aug-15-23 08:00AM
Aug-10-23 04:15PM
Aug-08-23 08:00AM
Jun-05-23 08:00AM
May-17-23 08:00AM
May-12-23 08:00AM
May-02-23 05:08PM
May-01-23 08:00AM
Apr-26-23 10:00AM
Apr-25-23 08:00AM
Apr-24-23 08:00AM
Apr-17-23 09:00AM
Apr-11-23 08:00AM
Mar-30-23 04:15PM
Mar-16-23 08:00AM
Mar-01-23 08:00AM
Feb-23-23 07:00AM
Feb-21-23 07:00AM
Jan-17-23 07:00AM
Jan-05-23 07:00AM
Jan-03-23 07:00AM
Dec-12-22 07:00AM
Dec-08-22 07:00AM
Nov-10-22 07:30AM
Nov-03-22 09:10AM
Nov-01-22 07:30AM
Sep-27-22 07:30AM
Sep-15-22 07:30AM
Sep-13-22 07:30AM
Sep-08-22 07:30AM
Aug-30-22 04:15PM
Aug-19-22 09:20AM
Aug-16-22 04:15PM
Aug-12-22 04:15PM
Aug-11-22 10:05PM
Jul-27-22 07:00AM
Jul-21-22 07:00AM
Jul-12-22 08:00AM
Jul-10-22 09:12AM
Jun-30-22 04:15PM
Jun-08-22 08:00AM
Jun-06-22 07:00AM
May-17-22 07:00AM
May-12-22 08:00AM
May-05-22 08:00AM
May-04-22 08:00AM
May-03-22 11:00AM
Apr-13-22 08:30AM
Apr-05-22 04:15PM
Mar-28-22 08:00AM
Mar-17-22 04:15PM
Mar-04-22 07:00AM
Feb-10-22 05:36PM
Jan-31-22 12:29PM
Jan-10-22 07:00AM
Jan-06-22 07:00AM
Dec-16-21 07:00AM
Dec-09-21 04:30PM
Nov-16-21 07:00AM
Nov-11-21 07:00AM
Nov-10-21 04:15PM
Nov-04-21 08:00AM
Nov-01-21 09:28AM
IN8bio, Inc. operates as a clinical stage biopharmaceutical company, which focuses on developing novel therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells. The company was founded by Lawrence S. Lamb and William T. Ho on February 8, 2016 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Graff Jeremy R.DirectorSep 13 '23Buy0.952,5002,3752,500Sep 15 04:51 PM
McCall PatrickChief Financial OfficerAug 25 '23Buy1.031,0001,0306,263Aug 28 04:43 PM
Ho William Tai-WeiPresident and CEOAug 24 '23Buy1.0523,80024,9902,339,545Aug 28 04:42 PM